Response to "Association of IDH1/2 mutation with preoperative seizure in low-grade gliomas: How strong is the evidence?"

被引：2
|
作者：
Wang, Zheng [1 ,2 ,3 ,4 ]
Zhang, Zhong [4 ,5 ]
Wang, Yinyan [1 ,2 ,3 ,4 ]
You, Gan [1 ,2 ,4 ,6 ]
Jiang, Tao [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China
[2] Beijing Inst Brain Disorders, Beijing, Peoples R China
[3] Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China
[4] Chinese Glioma Genome Atlas Network, Beijing, Peoples R China
[5] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China
[6] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China
来源：
EPILEPSY RESEARCH | 2015年 / 115卷
关键词：
D O I：
10.1016/j.eplepsyres.2015.06.004
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：145 / 146
页数：2
相关论文
共 50 条
  • [21] IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide
    Dubbink, H. J.
    Taal, W.
    van Marion, R.
    Kros, J. M.
    van Heuvel, I.
    Bromberg, J. E.
    Zonnenberg, B. A.
    Zonnenberg, C. B. L.
    Postma, T. J.
    Gijtenbeek, J. M. M.
    Boogerd, W.
    Groenendijk, F. H.
    Smitt, P. A. E. Sillevis
    Dinjens, W. N. M.
    van den Bent, M. J.
    NEUROLOGY, 2009, 73 (21) : 1792 - 1795
  • [22] A population-based study of low-grade gliomas and mutated isocitrate dehydrogenase 1 (IDH1)
    Dahlrot, Rikke H.
    Kristensen, Bjarne W.
    Hjelmborg, Jacob
    Herrstedt, Jorn
    Hansen, Steinbjorn
    JOURNAL OF NEURO-ONCOLOGY, 2013, 114 (03) : 309 - 317
  • [23] Noninvasive Prediction of IDH1 Mutation and ATRX Expression Loss in Low-Grade Gliomas Using Multiparametric MR Radiomic Features
    Ren, Yan
    Zhang, Xi
    Rui, Wenting
    Pang, Haopeng
    Qiu, Tianming
    Wang, Jing
    Xie, Qian
    Jin, Teng
    Zhang, Hua
    Chen, Hong
    Zhang, Yong
    Lu, Hongbing
    Yao, Zhenwei
    Zhang, Junhai
    Feng, Xiaoyuan
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2019, 49 (03) : 808 - 817
  • [24] Genetic Alteration Analysis of IDH1, IDH2, CDKN2A, MYB and MYBL1 in Pediatric Low-Grade Gliomas
    Barinfeld, Orit
    Zahavi, Alon
    Weiss, Shirel
    Toledano, Helen
    Michowiz, Shalom
    Goldenberg-Cohen, Nitza
    FRONTIERS IN SURGERY, 2022, 9
  • [25] Computational Analysis of IDH1, IDH2, and TP53 Mutations in Low-Grade Gliomas Including Oligodendrogliomas and Astrocytomas
    Bendahou, Mohammed Amine
    Arrouchi, Housna
    Lakhlili, Wiame
    Allam, Loubna
    Aanniz, Tarik
    Cherradi, Nadia
    Ibrahimi, Azeddine
    Boutarbouch, Mahjouba
    CANCER INFORMATICS, 2020, 19
  • [26] Tumor mutational burden predicts survival in patients with low-grade gliomas expressing mutated IDH1
    Alghamri, Mahmoud S.
    Thalla, Rohit
    Avvari, Ruthvik P.
    Dabaja, Ali
    Taher, Ayman
    Zhao, Lili
    Ulintz, Peter J.
    Castro, Maria G.
    Lowenstein, Pedro R.
    NEURO-ONCOLOGY ADVANCES, 2020, 2 (01)
  • [27] IDH1 MUTATION IS AN IMPORTANT FACTOR PREDICTING OUTCOME IN HIGH GRADE GLIOMAS
    Perez-Magan, E.
    Ruano, Y.
    Garcia-Claver, A.
    Juarez, R.
    Ferrara, P.
    Fiano, C.
    Ribalta, T.
    Mollejo, M.
    Rodriguez de Lope, A.
    Melendez, B.
    NEURO-ONCOLOGY, 2010, 12 : 33 - 33
  • [28] LIMITS OF IMMUNOHISTOCHEMISTRY IN DETECTION OF IDH1 MUTATIONS IN LOW GRADE GLIOMAS
    Jancalek, Radim
    Hermanova, Marketa
    Slaby, Ondrej
    NEURO-ONCOLOGY, 2017, 19 : 181 - 181
  • [29] Limits of immunohistochemistry in detection of IDH1 mutations in low grade gliomas
    Jancalek, R.
    Slaby, O.
    Hermanova, M.
    Brichtova, E.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 388 - 388
  • [30] Association Between IDH1 and IDH2 Mutations and Preoperative Seizures in Patients with Low-Grade Versus High-Grade Glioma: A Systematic Review and Meta-Analysis
    Phan, Kevin
    Ng, Wyatt
    Lu, Victor M.
    McDonald, Kerrie L.
    Fairhall, Jacob
    Reddy, Rajesh
    Wilson, Peter
    WORLD NEUROSURGERY, 2018, 111 : E539 - E545
12345